The Asia-Pacific IVF Services Market generated $8.10 billion in 2018, and is estimated to reach $24.21 billion by 2028, registering a CAGR of 11.6% from 2019 to 2028. The report offers an extensive analysis of changing market dynamics, supply chain, value chain, company profiles and competitive scenario.

Request Sample Report at: https://www.alliedmarketresearch.com/request-sample/853

Delayed -pregnancies in women, surge in infertility rates in Asia-Pacific, rise in gamete donations, and increase in IVF success rates drive the growth of the Asia-Pacific IVF services market. However, low awareness and difficulties associated with IVF treatment hinder the market growth. On the other hand, rise in number of fertility clinics create new opportunities in the coming years.

Covid-19 scenario:

According to ASPIRE-Asia Pacific Initiative on Reproduction, IVF services have come to halt during the coronavirus pandemic by considering the unknown effects of Covid-19 on embryos and pregnancy.
In Asia-Pacific, China has been severely affected by coronavirus, and to avoid the transmission in the new born babies, the sperm fertilization has been stopped in China.
The report offers a detailed segmentation of the Asia-Pacific IVF services market based on cycle type, end user, and countries.

Based on end user, the fertility clinics segment contributed to the largest share in 2019, accounting for nearly three-fifths of the total share, and is estimated to maintain its dominant position during the forecast period. However, the hospitals segment is expected to register the highest CAGR of 12.7% from 2019 to 2028.

Read Full Report @ https://www.alliedmarketresearch.com/asia-Pacific-in-vitro-fertilization-services-market

Based on cycle type, the fresh cycle (non-donor) segment accounted for the largest share in 2018, holding nearly two-thirds of the total share, and is expected to maintain the largest share throughout the forecast period. Moreover, this segment is estimated to portray the highest CAGR of 11.8% from 2019 to 2028. The report also analyzes the thawed IVF cycle (non-donor), and donor egg IVF cycle segment.

Based on country, China contributed the highest share, accounting for more than two-fifths of the total market share in 2018, and will maintain its dominance throughout the forecast period. However, India is expected to grow at the highest CAGR of 16.1% from 2019 to 2028.

For Purchase Enquiry: https://www.alliedmarketresearch.com/purchase-enquiry/853

Leading market players analyzed in the research include Apollo Hospitals Dhaka, Australian Concept Infertility Medical Center (ACIMC), Bahosi Fertility Centre, Bangkok IVF center, Bloom Fertility and Healthcare, Bloom Fertility Center, Bourn Hall Fertility Center, Bumrungrad International Hospital, Center for Advanced Reproductive Medicine and Infertility, CHA Fertility Center, and more.